Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

The New England Journal of Medicine
Marc LallemantPerinatal HIV Prevention Trial (Thailand) Investigators

Abstract

Although zidovudine prophylaxis decreases the rate of transmission of the human immunodeficiency virus (HIV) type 1 substantially, a large number of infants still become infected. We hypothesized that the administration, in addition to zidovudine, of a single dose of oral nevirapine to mothers during labor and to neonates would further reduce transmission of HIV. We conducted a randomized, double-blind trial of three treatment regimens in Thai women who were receiving zidovudine therapy during the third trimester of pregnancy. In one group, mothers and infants received a single dose of nevirapine (nevirapine-nevirapine regimen); in another, mothers and infants received nevirapine and placebo, respectively (nevirapine-placebo regimen); and in the last, mothers and infants received placebo (placebo-placebo regimen). The infants also received one week of zidovudine therapy and were formula-fed. The end point of the study was infection with HIV in the infants, established by virologic testing. Between January 15, 2001, and February 28, 2003, a total of 1844 Thai women were enrolled. At the first interim analysis, the independent data monitoring committee stopped enrollment in the placebo-placebo group. Among women who delivered bef...Continue Reading

References

Feb 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·B J SimpsonW A Andiman
Jan 5, 2002·Biometrics·R Balasubramanian, S W Lagakos
Feb 1, 2002·Human Reproduction·A M BucceriM Vignali
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ellen R CooperUNKNOWN Women and Infants' Transmission Study Group
Jun 14, 2002·The New England Journal of Medicine·Ruth E TuomalaMarc Bulterys
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Alejandro DorenbaumUNKNOWN International PACTG 316 Team
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Pornsinee AmornwichetSiripon Kanshana
Oct 22, 2002·Lancet·R C WimalasunderaG P Taylor
Aug 5, 2003·Antiviral Research·Robert J Visalli, Marja van Zeijl
Jul 13, 2004·The New England Journal of Medicine·Gonzague JourdainUNKNOWN Perinatal HIV Prevention Trial Group
Apr 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·S PalmerJ Coffin
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amphan ChalermchockcharoenkitJordan W Tappero

❮ Previous
Next ❯

Citations

Jul 13, 2006·Archives of Pharmacal Research·Rafik SamuelByungse Suh
Jan 8, 2011·AIDS and Behavior·Amin S HassanJames A Berkley
Apr 13, 2006·Current HIV/AIDS Reports·Mary A Vogler
Aug 19, 2005·Current Infectious Disease Reports·Matthew F Chersich, Glenda E Gray
Nov 15, 2007·Current Infectious Disease Reports·Katherine Luzuriaga
Aug 9, 2008·Current Infectious Disease Reports·Katherine A Belden, Kathleen E Squires
Jun 10, 2008·Indian Journal of Pediatrics·Sunil SaharanVinod K Paul
May 19, 2005·Social Science & Medicine·Kristine HopkinsJoseph E Potter
Sep 13, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Brian Eley
Oct 11, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Marie-Louise Newell
Jul 23, 2005·Reproductive Health Matters·James McIntyre
Sep 3, 2010·Chemical Research in Toxicology·Alexandra M M AntunesM Matilde Marques
Jul 4, 2008·Chemical Research in Toxicology·Alexandra M M AntunesM Matilde Marques
Nov 5, 2004·The New England Journal of Medicine·Christian Herzmann, Heiko Karcher
Jul 13, 2004·The New England Journal of Medicine·Hoosen Coovadia
Jul 13, 2004·The New England Journal of Medicine·Gonzague JourdainUNKNOWN Perinatal HIV Prevention Trial Group
Jun 18, 2010·The New England Journal of Medicine·Charles S ChaselaUNKNOWN BAN Study Group
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul ThistleMichael Silverman
Jan 10, 2008·The Journal of Infectious Diseases·Tammy MeyersGayle Sherman
Jan 10, 2008·The Journal of Infectious Diseases·Lisa R HirschhornWilliam Rodriguez
Nov 17, 2007·The Journal of Infectious Diseases·Gonzague JourdainUNKNOWN Perinatal HIV Prevention Trial Group, Thailand
Jan 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick A CoffieFrançois Dabis
Jan 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashraf CoovadiaLouise Kuhn
Nov 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Renaud BecquetFrançois Dabis
Feb 18, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc LallemantUNKNOWN PHPT-4 Study Team
Apr 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gonzague JourdainUNKNOWN Program for HIV Prevention and Treatment (PHPT) Study Group
Nov 9, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Intira J CollinsUNKNOWN Program for HIV Prevention and Treatment Study Team
Sep 23, 2006·AIDS Research and Human Retroviruses·Lisa M FrenkelRobert W Coombs
May 30, 2008·AIDS Research and Human Retroviruses·Luis E Soto-RamirezUNKNOWN NISDI Perinatal Study Group
Dec 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell B Van DykeUNKNOWN IMPAACT P1032 Protocol Team
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Woottichai KhamduangUNKNOWN Program for HIV Prevention and Treatment (PHPT-2) group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.